187 related articles for article (PubMed ID: 11001879)
1. Modulation of hemostatic mechanisms in bacterial infectious diseases.
Tapper H; Herwald H
Blood; 2000 Oct; 96(7):2329-37. PubMed ID: 11001879
[No Abstract] [Full Text] [Related]
2. Blood coagulation and coagulation tests.
Bennett JS
Med Clin North Am; 1984 May; 68(3):557-76. PubMed ID: 6431207
[TBL] [Abstract][Full Text] [Related]
3. Coagulation, fibrinolytic and kallikrein systems in neonates with uncomplicated sepsis and septic shock.
Roman J; Velasco F; Fernandez F; Fernandez M; Villalba R; Rubio V; Vicente A; Torres A
Haemostasis; 1993; 23(3):142-8. PubMed ID: 8276317
[TBL] [Abstract][Full Text] [Related]
4. The occurrence and significance of fibrin-fibrinogen degradation products (FDP) in acute infections.
Skånsberg P; Cronberg S; Nilsson IM
Scand J Infect Dis; 1974; 6(2):197-203. PubMed ID: 4854978
[No Abstract] [Full Text] [Related]
5. Crosstalk of the plasma contact system with bacteria.
Nickel KF; Renné T
Thromb Res; 2012 Oct; 130 Suppl 1():S78-83. PubMed ID: 23026673
[TBL] [Abstract][Full Text] [Related]
6. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
[TBL] [Abstract][Full Text] [Related]
7. Degradation products of fibrinogen and fibrin in bacteremia due to gram-negative rods.
Satterwhite TK; Hawiger J; Burklow SL; Koenig MG
J Infect Dis; 1973 Apr; 127(4):437-41. PubMed ID: 4694546
[No Abstract] [Full Text] [Related]
8. New insights into the pathogenesis and therapy of sepsis and septic shock.
Llewelyn M; Cohen J
Curr Clin Top Infect Dis; 2001; 21():148-71. PubMed ID: 11572150
[No Abstract] [Full Text] [Related]
9. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
Colick JA; Fisher LM
Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
[No Abstract] [Full Text] [Related]
10. Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock.
Andersen MG; Hvas CL; Tønnesen E; Hvas AM
Acta Anaesthesiol Scand; 2014 May; 58(5):525-33. PubMed ID: 24580049
[TBL] [Abstract][Full Text] [Related]
11. Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia.
Barton MH; Morris DD; Norton N; Prasse KW
J Vet Intern Med; 1998; 12(1):26-35. PubMed ID: 9503357
[TBL] [Abstract][Full Text] [Related]
12. An overview of hemostasis.
Troy GC
Vet Clin North Am Small Anim Pract; 1988 Jan; 18(1):5-20. PubMed ID: 3282384
[TBL] [Abstract][Full Text] [Related]
13. [Clinical aspects and therapy of disseminated intravascular coagulation].
Lasch HG
Hamatol Bluttransfus; 1970; 9():121-31. PubMed ID: 5508064
[No Abstract] [Full Text] [Related]
14. Time course of hemostatic abnormalities in sepsis and its relation to outcome.
Lorente JA; García-Frade LJ; Landín L; de Pablo R; Torrado C; Renes E; García-Avello A
Chest; 1993 May; 103(5):1536-42. PubMed ID: 8486040
[TBL] [Abstract][Full Text] [Related]
15. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
[TBL] [Abstract][Full Text] [Related]
16. [Severe sepsis and septic shock: crossroad between inflammation and coagulation].
Torrabadella De Reynoso P
Med Clin (Barc); 2002 Apr; 118(13):517-8. PubMed ID: 11975893
[No Abstract] [Full Text] [Related]
17. [Intravascular coagulation and degradation products of fibrinogen and fibrin. (Review of new findings and diagnostic possibilities].
Hrubisková K
Bratisl Lek Listy; 1974; 62(1):111-9. PubMed ID: 4603642
[No Abstract] [Full Text] [Related]
18. Hemostatic changes in neonates with anoxia and sepsis.
Dube B; Das BK; Kolindewala JK; Dube RK; Bhargava V
Indian Pediatr; 1989 Jan; 26(1):26-31. PubMed ID: 2759692
[TBL] [Abstract][Full Text] [Related]
19. Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome.
Hesselvik JF; Blombäck M; Brodin B; Maller R
Crit Care Med; 1989 Aug; 17(8):724-33. PubMed ID: 2502362
[TBL] [Abstract][Full Text] [Related]
20. Human fibrinogen.
Shafer JA; Higgins DL
Crit Rev Clin Lab Sci; 1988; 26(1):1-41. PubMed ID: 3286116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
